EFFECTS OF ANTIMETABOLITES ON RNA METABOLISM
EFFECTS OF ANTIMETABOLITES ON RNA METABOLISM
批准号:
3172016
负责人:
BRUCE JEFFREY DOLNICK
金额:
$7.9万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-05-01 至 1993-12-31
关键词:
DNA replication RNA biosynthesis RNA splicing antimetabolites antineoplastics cell bank /registry cell type dihydrofolate reductase drug metabolism drug resistance floxuridine fluorouracil human tissue messenger RNA methotrexate neoplasm /cancer pharmacology nucleic acid metabolism polymerase chain reaction precursor mRNA ribosomal RNA
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The purpose of this application is to extend previous studies of the
effects of 5-fluorouracil (FUra) on RNA metabolism in an effort to better
understand the RNA mediated effects of FUra cytotoxicity. This study will
focus on two FUra induced aberrations of mRNA metabolism, pre-mRNA splicing
and mRNA half life. It is specifically proposed that the following be
accomplished:
1. Apply the polymerase chain reaction to quantitate steady state levels
of dihydrofolate reductase (DHFR) RNA splicing substrates as well as
splicing intermediates in the pre-mRNA processing pathway, in FUra treated
and control cells. Extend this assay to non-gene amplified cells so that
it may eventually be applied in vivo.
2. Measure the half life of 3.5 kb DHFR mRNA in cells grown in the
presence or absence of FUra. Assess whether an increased half-life after
cell growth in medium containing FUra is an explanation for the previously
observed increase in this specific DHFR mRNA. Identify the 3' noncoding
element(s) present in 3.5 kb DHFR mRNA which appear to mediate this effect
of FUra on half-life deletion mapping and DNA transfection.
3. Study the effect of FUra pretreatment on methotrexate cytotoxicity in
cells expressing mRNAs with altered 3' noncoding regions to correlate
alterations in mRNA half life with DHFR drug responsiveness.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Quantitation of dihydrofolate reductase and thymidylate synthase mRNAs in vivo and in vitro by polymerase chain reaction.
通过聚合酶链反应对体内和体外二氢叶酸还原酶和胸苷酸合酶 mRNA 进行定量。
DOI:
--
发表时间:
1992
期刊:
Oncology research
影响因子:
3.1
作者:
[Dolnick,BJ, Zhang,ZG, Hines,JD, Rustum,YM]
通讯作者:
Rustum,YM
5-Fluorouracil augmentation of dihydrofolate reductase gene transcripts containing intervening sequences in methotrexate-resistant KB cells.
5-氟尿嘧啶增强甲氨蝶呤耐药 KB 细胞中含有插入序列的二氢叶酸还原酶基因转录本。
DOI:
--
发表时间:
1986
期刊:
Molecular pharmacology
影响因子:
3.6
作者:
[Will,CL, Dolnick,BJ]
通讯作者:
Dolnick,BJ
DOI:
10.1016/s0021-9258(18)68949-5
发表时间:
1988-03
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[S. Doong;B. Dolnick]
通讯作者:
S. Doong;B. Dolnick
5-Fluorouracil alters dihydrofolate reductase pre-mRNA splicing as determined by quantitative polymerase chain reaction.
通过定量聚合酶链式反应测定,5-Fluorouracil 会改变二氢叶酸还原酶前体 mRNA 剪接。
DOI:
--
发表时间:
1993
期刊:
Molecular pharmacology
影响因子:
3.6
作者:
[Wu,XP, Dolnick,BJ]
通讯作者:
Dolnick,BJ
Mutation(s) of the thymidylate synthase gene of human adenocarcinoma cells causes a thymidylate synthase-negative phenotype that can be attenuated by exogenous folates.
人腺癌细胞胸苷酸合酶基因的突变导致胸苷酸合酶阴性表型,该表型可被外源叶酸减弱。
DOI:
--
发表时间:
1992
期刊:
Cancer research
影响因子:
11.2
作者:
[Houghton,PJ, Rahman,A, Will,CL, Dolnick,BJ, Houghton,JA]
通讯作者:
Houghton,JA
共 9 条
Validation of rTS as a Molecular Target
-
批准号:6515047
-
项目类别:
-
资助金额:$16.72万
-
财政年份:2001
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
Validation of rTS as a Molecular Target
-
批准号:6334042
-
项目类别:
-
资助金额:$16.53万
-
财政年份:2001
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
QUORUM SENSING IN HUMAN CELLS
-
批准号:6377966
-
项目类别:
-
资助金额:$23.09万
-
财政年份:2000
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
QUORUM SENSING IN HUMAN CELLS
-
批准号:6159431
-
项目类别:
-
资助金额:$23.09万
-
财政年份:2000
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
QUORUM SENSING IN HUMAN CELLS
-
批准号:6514606
-
项目类别:
-
资助金额:$23.09万
-
财政年份:2000
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
QUORUM SENSING IN HUMAN CELLS
-
批准号:6610990
-
项目类别:
-
资助金额:$23.09万
-
财政年份:2000
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
EDITING OF THYMIDYLATE SYNTHASE RNA
-
批准号:6497524
-
项目类别:
-
资助金额:$23.56万
-
财政年份:1999
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
EDITING OF THYMIDYLATE SYNTHASE RNA
-
批准号:6350349
-
项目类别:
-
资助金额:$22.99万
-
财政年份:1999
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
EDITING OF THYMIDYLATE SYNTHASE RNA
-
批准号:2806096
-
项目类别:
-
资助金额:$17.18万
-
财政年份:1999
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
EDITING OF THYMIDYLATE SYNTHASE RNA
-
批准号:6150367
-
项目类别:
-
资助金额:$20.48万
-
财政年份:1999
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
ANTISENSE SUPPRESSION OF MDRL GENE EXPRESSION
-
批准号:6236035
-
项目类别:
-
资助金额:$0.83万
-
财政年份:1994
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
HUMAN THYMIDYLATE SYNTHASE ANTISENSE RNA
-
批准号:3201987
-
项目类别:
-
资助金额:$12.59万
-
财政年份:1992
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
RTS AND ITS ROLE IN CHEMOTHERAPY
-
批准号:2837666
-
项目类别:
-
资助金额:$14.73万
-
财政年份:1992
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
HUMAN THYMIDYLATE SYNTHASE ANTISENSE RNA
-
批准号:2098374
-
项目类别:
-
资助金额:$13.53万
-
财政年份:1992
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
RTS AND ITS ROLE IN CHEMOTHERAPY
-
批准号:2008111
-
项目类别:
-
资助金额:$14.19万
-
财政年份:1992
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
RTS AND ITS ROLE IN CHEMOTHERAPY
-
批准号:2608094
-
项目类别:
-
资助金额:$14.3万
-
财政年份:1992
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
HUMAN THYMIDYLATE SYNTHASE ANTISENSE RNA
-
批准号:3201988
-
项目类别:
-
资助金额:$13.43万
-
财政年份:1992
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
ANTISENSE AS AN APPROACH TO CANCER CHEMOTHERAPY
-
批准号:3193028
-
项目类别:
-
资助金额:$9.76万
-
财政年份:1988
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
ANTISENSE AS AN APPROACH TO CANCER CHEMOTHERAPY
-
批准号:3193029
-
项目类别:
-
资助金额:$8.92万
-
财政年份:1988
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
EFFECTS OF ANTIMETABOLITES ON RNA METABOLISM
-
批准号:3172017
-
项目类别:
-
资助金额:$12.11万
-
财政年份:1988
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
海外基金